ABSTRACT A study was designed to investigate whether asthma, when carefully managed, is associated with an increased risk of complications in connection with pregnancy. One hundred and eighty one asthmatic women were monitored during 198 pregnancies. Antiasthmatic treatment consisted of inhaled f2 adrenergic drugs, beclomethasone, sodium cromoglycate, oral theophylline, and systemic corticosteroids as needed. Postpartum information on asthmatic symptoms and infant feeding was collected by means of a questionnaire. A control group of 198 non-asthmatic pregnant women was matched for age and parity. Atopic women had less severe asthma than non-atopic women. During pregnancy 40% of the patients were managed with the same antiasthmatic medication as before pregnancy; 18% needed less and 42% more medication. Pre-eclampsia occurred more often in asthmatic than control subjects, especially in patients with severe asthma. Hypoglycaemia occurred more often in infants of mothers with severe asthma than in infants of mothers with less severe disease. Theophylline medication at term did not influence labour or delivery. Asthma caused no emergencies during labour. Among the asthmatic subjects 28% ofbabies were delivered by caesarean section compared with 17% in the control group. There was no difference between asthmatic and control subjects with regard to length of gestation, birth weight, incidence of perinatal deaths, low Apgar scores, neonatal respiratory difficulties, hyperbilirubinaemia, or malformations. It is concluded that severe asthma or systemic corticosteroid treatment (or both) during pregnancy seems to increase the incidence of mild pre-eclampsia in the mother and hypoglycaemia in the infant. The findings suggest that careful supervision of asthma during pregnancy and labour by obstetricians and chest physicians working in close collaboration should prevent most of the serious obstetric and neonatal complications of asthma in pregnancy reported by previous authors.
Gluck and Gluck,' after a prospective study, reported that symptoms of asthma worsened during pregnancy in 43% of patients and improved in 14%. Exacerbation of asthmatic symptoms usually occurs during the last trimester,' although women with extrinsic (atopic) asthma tend to have fewer symptoms during pregnancy than patients with intrinsic asthma.2 Bronchial asthma in the mother has been associated with increased perinatal morbidity and mortality,34 and also with increased morbidity during infancy. 3 Obstetric complications have been observed more often in asthmatic than in control subjects,3 though it is uncertain whether the complications connected with pregnancy are due to the asthma itself or to the drugs used to treat it.
Because most pharmaceutical companies place restrictions or cautions against the use of drugs during pregnancy, many physicians advise their patients to avoid or decrease their medication. There seems to be no argument, however, against the use of most antiasthmatic drugs during pregnancy."
To investigate the effect of asthma on pregnancy further we performed a prospective four year study on the outcome of pregnancy in asthmatic patients. Our aim was to give the optimum treatment for the asthma so far as possible and to monitor carefully the progress of the pregnancy and the condition ofthe fetus and the newborn infant. 12 Asthma and pregnancy: a prospective study of 198 pregnancies Methods THE SUBJECTS We followed 198 pregnancies lasting 24 weeks or more in 181 women with asthma. The patients were seen in the departments of pulmonary medicine and of obstetrics and gynaecology at the University Central Hospital of Helsinki during 1978-82.
A control group of 198 non-asthmatic women were collected retrospectively from the labour records. The control subjects were matched for age (± 2 years), parity (primipara or multipara), and time of delivery (the closest possible date after that of the reference case). Relative birth weights (SD units) were calculated separately for girls and boys on the basis of a Finnish reference population.
Seventeen patients had two pregnancies during the investigation period. Two pairs of twins were born to the mothers with asthma and one pair to the mothers in the control group. Thus the total number of newborn infants was 200 in the study group and 199 in the control group.
Clinical data on the patients are shown in table 1. Patients were referred to us by maternity centres or physicians in out patient practice. Twenty per cent of the patients were admitted to the study during the first trimester of pregnancy, 54% during the second, and 26% during the third. All patients satisfied the criteria of asthma set by the American Thoracic Society and More than half of the atopic subjects (59%) belonged to groups I and II (very mild or mild asthma), whereas most of the non-atopic subjects (59%) belonged to groups III and IV (moderately severe or severe asthma). The difference is significant (p < 0 05). Forty per cent of the patients managed with the same maintenance medication as before pregnancy, whereas 42% needed more and 18% less medication than before. There was no difference between atopic and non-atopic women in this respect. Further data depicting the course of asthma during pregnancy in atopic and non-atopic patients are shown in table 3. Patients in group IV had significantly lower values for FEV, and for maximum flow at 50% vital capacity (Vmax50) during the last month of pregnancy, although these tests were done in a clinically stable phase of the asthma (table 4) .
Asthmatic symptoms during labour were mild and easily controlled by means of a self administered #2
agonist from a metered dose inhalation device. None of the patients needed intensive antiasthmatic treatment during labour. Ninety one per cent of the mothers returned the postpartum questionnaire. About half of the infants were breast fed for six months or more. The corresponding figure for the control group is not available. There was no difference in the length of breast feeding between the severity groups.
According to the questionnaire, 26% of the patients thought that their asthma deteriorated after delivery, whereas 34 5% stated that they felt better. There was no difference between atopic and non-atopic patients 
COMPLICATIONS DURING PREGNANCY AND LABOUR
There was no difference between asthmatic and control subjects with regard to the length of gestation. There were no cases of eclampsia. Pre-eclampsia was observed significantly (p < 0 001) more often in the asthmatic than in the control group (146% v 4 5%) (table 5 ). The incidence of mild pre-eclampsia was three times higher (29%) in group IV (p < 005) than in group I (patients with mild asthma-8-7%). Proteinuria was more frequent in asthmatic (4%) than control subjects (2%) and in groups III and IV (6%) than in groups I and 11 (3%), though the differences were not significant. Pre-eclampsia occurred significantly more frequently (25%, p < 0-01) in patients who had received systemic steroids at some time than in those who had not ( 10% ). The incidence of maternal complications other than pre-eclampsia was no higher in asthmatic than in control women (table 5) .
MODE OF DELIVERY
The incidence of interventions in the form of induction or enhancement of labour was no greater in asthmatic than in control women, nor was there any difference between severity groups. Caesarean sections were performed more frequently in the asthmatic than in the control women (table 6) . Severe asthma was the main indication in eight of the 26 patients having elective caesarean sections, seven of them belonging to group IV. The operation was carried out when the asthma was adequately controlled. In no instance was severe, acute asthma the direct reason for a caesarean section. Emergency caesarean sections occurred with equal frequency and were performed for similar reasons in asthmatic and control subjects.
Prolongation of the third phase of delivery (,a 15 min) and haemorrhage (.' 1000 ml) occurred more 10 14 Vaginal delivery for breech presentation 14 [7] *p < 0 05, compared with groups I-II.
often among patients who had received theophylline by mouth at the time of delivery than among those who had not been given theophylline or among control subjects, though the differences were not significant. The severity of asthma had less influence on these measures than theophylline medication.
PERINATAL OUTCOME
The birth weight of the child did not differ between asthmatic and control groups (table 7) and was not affected by the severity of asthma. The incidence of perinatal death, low Apgar scores, respiratory difficulties, hyperbilirubinaemia, and malformations was no higher among the infants of asthmatic mothers than among the control infants. A low Apgar score in the infant was not related to exacerbations of asthma in the mother.
Hypoglycaemia in the newborn infants was no more common in the asthmatic than in the control groups but it occurred more frequently (p < 0 05) in groups III and IV than in groups I and II. There was, however, no significant relation between hypoglycaemia of the infant and pre-eclampsia in the mother.
Discussion
In Finland labour and deliveries take place in municipal or university hospitals in our district 40% in the latter. The common practice is to refer complicated cases to the university hospital, so we assume that our sample represents at least 40% of all asthmatic women giving birth in our district during the four years of the study. Patients with severe or troublesome asthma or with difficulties in tolerating treatment may be overrepresented because they may have been more readily Stenius-Aarniala, Piirila, Teramo referred than patients with mild or stable disease.
Our findings do not agree with previously reported observations that asthma or atopic disease in the mother is associated with prematurity,34" perinatal death,3 low Apgar score,3 respiratory difficulties,' hyperbilirubinaemia,'2 or low birth weight.3"4 "3 In earlier reports complications are probably attributable to the disease itself, as antiasthmatic treatment was less efficient at the time. Thus asthmatic patients were considered to be high risk patients, resulting in some instances in premature induction of labour. Since our aim was to maintain patients as symptom free as possible, none of our patients had severe bronchial obstruction continuously throughout pregnancy. Moreover, ephedrine was probably used in the patients in earlier studies, whereas it was avoided in our series. Ephedrine may lessen uterine blood flow'4 and thus decrease the birth weight.
Reports on the adverse effects of corticosteroid treatment during pregnancy are contradictory. Apgar'" reported an increased incidence of cleft palate in two series of pregnancies in women treated with systemic corticosteroids in early pregnancy. The incidence of stillbirths was eight times higher in women having continuous steroid treatment than in a corresponding group of untreated women with the same diseases.'6 The alarming findings in these studies may in part be the result of severe underlying disease rather than the treatment. Two studies of pregnant asthmatic women, some having short term and some long term systemic corticosteroids, showed no complications attributable to steroid treatment.'7 8 An association between asthma and pre-eclampsia of pregnancy has been reported. 4 We confirmed this, but the fact that blood pressure was measured slightly more frequently in the women with asthma (16 times on average) than in controls (14 times) might have contributed to our results. The cases of pre-eclampsia in our study were mild. Only a few patients had albuminuria, and there were no cases of eclampsia. In our study the incidence of pre-eclampsia in the mother and hypoglycaemia in the newborn were higher in the groups with more severe asthma, groups III and IV. These groups, however, contain the patients who had occasional or continuous systemic steroids during pregnancy, making it difficult to separate the influence of systemic corticosteroids from that of severe asthma.
In a study'9 on the outcome of pregnancy in women requiring systemic corticosteroids, the complications were attributed to acute exacerbations of asthma rather than to corticosteroid treatment. Although the direct effects of systemic steroids on the fetus appear to be small, their indirect effects will still form a risk for the infant. Since, however, an acute exacerbation of asthma carries even greater risks for both mother and child, systemic steroids should not be withheld when
